Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme

By Kuijlen Jos MA   Mooij Jan   Platteel Inge   Hoving Eelco W   Graaf Winette   Span Mark   Hollema Harry   Dunnen Wilfred  

Journal of Neuro-Oncology, Vol. 78, Iss. 2, 2006-06 ,pp. : 161-171

Springer Publishing Company

Access to resources Recommend Favorite

Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 19-27

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen Receptor Coregulatory Proteins as Potential Therapeutic Targets in the Treatment of Prostate Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1121-1130

Spandidos Publications

Access to resources Recommend Favorite